Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Gynecol Oncol. 2014 Apr 12;133(3):546–551. doi: 10.1016/j.ygyno.2014.04.002

Table 1. Overall Study Cohort Characteristics.

Variable N %

Age 18 - 30 years 3 2.0
31 – 50 years 30 19.7
51 – 70 years 92 60.5
Over 70 years 27 17.8
BMI
Under 25.0 27 17.8
25.0 – 29.9 27 17.8
30.0 – 39.9 68 44.7
Over 40.0 30 19.7
Race/Ethnicity1
White 120 79.0
Black 22 14.5
Hispanic 3 2
Native American 3 2
Asian 2 1.3
Other 2 1.3
Insurance
Private 108 71.0
Uninsured 32 21.0
Medicare only 7 4.6
Medicaid 5 3.2
Employment
Part Time 24 15.8
Full Time 51 33.6
Unemployed/Retired 77 50.1
Marital Status
Married/Partnered 67 44.0
Single/Divorced/Widowed 17 11.2
Unknown 68 44.5
Past Medical History
Obesity 98 64.5
Prior Laparotomy 35 23.0
Diabetes2 30 19.7
Pulmonary Disease2 4 2.6
HTN 75 49.3
Chronic Kidney Disease2 2 1.3
Cardiac Disease (CHF/CAD/MI) 2 15 9.9
Arthritis 13 8.6
Immunocompromise2 2 1.3
History of Cancer 28 18.4
Substance Abuse 18 11.8
Major Comorbidity3 43 28.3
Mental Health
Substance Abuse 18 11.8
Depression 24 15.8
Anxiety 18 11.8
Chronic Pain 5 3.3
Cancer Site
Uterine 94 61.8
Ovarian 26 17.1
Cervical 17 11.1
Vulva/Vaginal 9 5.9
Gyn NOS4 3 2.0
GI5 3 2.0
Cancer Stage
Stage I - II 98 64.5
Stage III - IV 46 30.3
Unstaged 8 5.3
1

NIH defined self-reported race/ethnicity.

2

Indicates inclusion in Major Comorbidity composite variable.

3

Indicates inclusion in Major Comorbidity composite variable.

4

Gyn Not Otherwise Specified – Either gynecologic cancer of unknown origin (2) or dual gynecologic primary(1).

5

Gastrointestinal – 3 patients with suspected ovarian cancer that had primary GI malignancy on final pathology.